Immunoprecise Antibodies (IPA.V) and research institute for artificial intelligence and machine learning, Mila Institute, inked a research partnership today, according to a press release.

The two companies will collaborate to research and develop initiatives, focusing on using data and artificial intelligence to change therapeutic discovery and development.

“This partnership reflects IPA’s deep-seeded commitment to innovation. Combining our efforts with the world-renowned talent at Mila catalyzes our advancements beyond the traditional life science model, as we continue to embrace the future of therapeutic discovery to accelerate the commercialization of life-saving therapeutics,” said Dr. Jennifer Bath, chief executive officer of Immunoprecise.

The Mila Institute was founded by professor Yoshua Bengio, the co-recipient of the 2018 ACM A.M. Turing Award. The institute has been recognized for its contributions to deep learning and in the fields of language modelling, machine translation, object recognition and generative design.

“This partnership opens up an exciting opportunity for AI to tap into unexplored data sets generated by Immunoprecise’s effective and high-throughput therapeutic antibody discovery platforms, to contribute to the design of new therapeutics against life-threatening diseases that challenge humanity,” said Bengio.

Immunoprecise recently completed a feasibility study, with the help of LaPort Expert Conseil, for the design of a good manufacturing certified facility. Their partnerships with Mila and LaPort were put together by Montreal International.

—Joseph Morton

Written By:

Joseph Morton

Joseph is a Vancouver-based author and journalist with both a communications degree and journalism diploma (and a few novels) under his belt. His joie de vivre is to spin difficult technical topics into more human-centric narratives. Buy him a coffee and he'll talk your ear off for hours about privacy issues, blockchain, cryptocurrency and martial arts. Don't talk to him if you're either a tomato, a bully, or if you're not a fan of either 1984 or Tender is the Night. No. You can still talk to him. Just be prepared to be told why you're wrong.

More By This Author
Tags:
Artificial Intelligence
Technology
ACM A.M Turing Award
Artificial intelligence
ImmunoPrecise
Immunoprecise Antibodies
IPA.V
LaPort Expert Conseil
machine learning
Mila Institute
Montreal International
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x